Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 9/2016

01-09-2016 | Erratum

Erratum to: The internal and external responsiveness of Functional Assessment of Cancer Therapy-Prostate (FACT-P) and Short Form-12 Health Survey version 2 (SF-12 v2) in patients with prostate cancer

Auteurs: Edmond P. H. Choi, Carlos K. H. Wong, Eric Y. F. Wan, James H. L. Tsu, W. Y. Chin, Kenny Kung, M. K. Yiu

Gepubliceerd in: Quality of Life Research | Uitgave 9/2016

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Excerpt

In the original publication of the article, the values in the row with row head (FACT-P total score**) of Table 1 have been moved to the next line inadvertently. However, the correct table is as follows (Table  1):
Table 1
Baseline characteristics of prostate cancer patients
 
Baseline ( N = 291)
Follow-up ( N = 168)
Attrition ( N = 123)
N
%
N
%
N
%
Demographic characteristics
           
 Age, mean (SD)**
74.9 (8.6)
 
72.9 (8.0)
 
77.7 (8.7)
 
 Education ##
  No formal schooling
46
15.8
16
9.5
30
24.4
  Primary
98
33.7
58
34.5
40
32.5
  Secondary
90
30.9
64
38.1
26
21.1
  Tertiary or above
53
18.2
28
16.7
25
20.3
  Unknown
4
1.4
2
1.2
2
1.6
 Marital status #
  Married
222
76.3
138
82.1
84
68.3
  Single
17
5.8
10
6.0
7
5.7
  Separated, divorced or widower
48
16.5
18
10.7
30
24.4
  Unknown
4
1.4
2
1.2
2
1.6
 Currently working
  Yes
25
8.6
20
11.9
5
4.1
  No
262
90.0
146
86.9
116
94.3
  Unknown
4
1.4
2
1.2
2
1.6
 Monthly income (HKD$)
  <20,000
238
81.8
133
79.2
105
85.4
  >20,000
49
16.8
33
19.6
16
13.0
  Unknown
4
1.4
2
1.2
2
1.6
Clinical characteristics
 PSA
  <0.1 ng/ml
109
37.5
70
41.7
39
31.7
  >0.1 and <10 ng/ml
121
41.6
60
35.7
61
49.6
  >10 ng/ml
39
13.4
24
14.3
15
12.2
  Unknown
22
7.6
14
8.3
8
6.5
 AJCC cancer stage
  I
58
19.9
27
16.1
31
25.2
  II
75
25.8
42
25.0
33
26.8
  III
31
10.7
20
11.9
11
8.9
  IV
112
38.5
70
41.7
42
34.1
  Unknown
15
5.2
9
5.4
6
4.9
 Distant metastasis
59
20.3
37
22.0
22
17.9
 KPS ##
  Mean (SD)**
91.4 (12.5)
 
94.1 (8.7)
 
87.6 (15.6)
 
  <70
23
7.9
5
2.98
18
14.6
  80
34
11.7
16
9.52
18
14.6
  90
64
22.0
39
23.21
25
20.3
  100
138
47.4
90
53.57
48
39.0
  Unknown
32
11.0
18
10.71
14
11.4
 Treatments
  Watchful waiting/active surveillance
24
8.12
12
7.1
12
9.8
  Androgen deprivation/combined androgen blockade
117
40.2
65
38.7
52
42.3
  Radical prostatectomy #
102
35.1
68
40.5
34
27.6
  Radical curative radiation
45
15.5
26
15.5
19
15.4
  Adjuvant radiation
8
2.7
4
2.4
4
3.3
  Chemotherapy
4
1.4
2
1.2
2
1.6
HRQOL scores
Mean (SD)
Mean (SD)
Mean (SD)
Condition-specific, FACT-P
 PWB**
24.6 (3.6)
25.7 (2.6)
23.2 (4.3)
 SWB**
19.6 (5.2)
20.6 (4.3)
18.3 (6.0)
 EWB
21.1 (3.8)
21.4 (3.3)
20.7 (4.3)
 FWB**
19.7 (5.4)
20.9 (4.7)
18.1 (5.8)
 PCS**
35.9 ± (6.5)
37.5 (5.6)
33.7 (6.9)
 TOI**
80.2 ± (13.7)
84.0 (11.3)
75.0 (15.0)
 FACT-G total score**
85.0 ± (13.9)
88.5 (11.6)
80.3 (15.4)
 FACT-P total score**
120.9 ± (19.2)
126.0 (16.0)
114.0 (21.1)
Generic, SF-12v2
 PF**
67.2 (34.7)
78.7 (28.4)
51.2 (36.3)
 RP**
71.1 (26.9)
78.9 (22.8)
60.5 (28.4)
 BP**
75.1 (27.6)
82.6 (22.2)
64.7 (30.9)
 GH**
59.4 (27.2)
67.1 (24.1)
48.8 (27.9)
 VT**
70.1 (24.6)
75.1 (23.3)
63.1 (24.7)
 SF**
76.7 (26.2)
82.9 (22.6)
68.2 (28.4)
 RE*
84.8 (22.2)
87.6 (19.4)
80.9 (25.2)
 MH**
81.3 (19.3)
84.4 (17.3)
76.8 (21.0)
 PCS-12**
43.4 (13.5)
47.8 (10.7)
37.3 (14.6)
 MCS-12
57.4 (9.9)
58.0 (8.9)
56.5 (11.2)
SD standard deviation, PSA prostate-specific antigen, KPS Karnofsky performance status, AJCC American Joint Committee on Cancer, HRQOL health-related quality of life, FACT-P subscales, PWB physical well-being, SWB social well-being, EWB emotional well-being, FWB functional well-being, PCS prostate cancer subscale, TOI trial outcome index, SF-12v2 subscales, PF physical functioning, RP role physical, BP bodily pain, GH general health, VT vitality, SF social functioning, RE role emotional, MH mental health, PCS- 12 physical component summary 12, MCS- 12 mental component summary 12
P value < 0.05 by independent t test
**  P value < 0.01 by independent t test
# P value < 0.05 by Chi-square test
## P value < 0.01 by Chi-square test

Met onderstaand(e) abonnement(en) heeft u direct toegang:

BSL Podotherapeut Totaal

Binnen de bundel kunt u gebruik maken van boeken, tijdschriften, e-learnings, web-tv's en uitlegvideo's. BSL Podotherapeut Totaal is overal toegankelijk; via uw PC, tablet of smartphone.

Metagegevens
Titel
Erratum to: The internal and external responsiveness of Functional Assessment of Cancer Therapy-Prostate (FACT-P) and Short Form-12 Health Survey version 2 (SF-12 v2) in patients with prostate cancer
Auteurs
Edmond P. H. Choi
Carlos K. H. Wong
Eric Y. F. Wan
James H. L. Tsu
W. Y. Chin
Kenny Kung
M. K. Yiu
Publicatiedatum
01-09-2016
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 9/2016
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-016-1279-5